Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity - PubMed (original) (raw)

Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity

Matthew F Peters et al. J Biomol Screen. 2009 Mar.

Abstract

G-protein-coupled receptors can couple to different signal transduction pathways in different cell types (termed cell-specific signaling) and can activate different signaling pathways depending on the receptor conformation(s) stabilized by the activating ligand (functional selectivity). These concepts offer potential for developing pathway-specific drugs that increase efficacy and reduce side effects. Despite significant interest, functional selectivity has been difficult to exploit in drug discovery, in part due to the burden of multiple assays. Cellular impedance assays use an emerging technology that can qualitatively distinguish Gs, Gi/o, and Gq signaling in a single assay and is thereby suited for studying these pharmacological concepts. Cellular impedance confirmed cell-specific Gs and Gq coupling for the melanocortin-4 receptor and dual Gi and Gs signaling with the cannabinoid-1 (CB1) receptor. The balance of Gi versus Gs signaling depended on the cell line. In CB1-HEKs, Giand Gs-like responses combined to yield a novel impedance profile demonstrating the dynamic nature of these traces. Cellspecific signaling was observed with endogenous D1 receptor in U-2 cells and SK-N-MC cells, yet the pharmacological profile of partial and full agonists was similar in both cell lines. We conclude that the dynamic impedance profile encodes valuable relative signaling information and is sufficiently robust to help evaluate cell-specific signaling and functional selectivity.

PubMed Disclaimer

Similar articles

• Comparing label-free biosensors for pharmacological screening with cell-based functional assays.
  Peters MF, Vaillancourt F, Heroux M, Valiquette M, Scott CW. Peters MF, et al. Assay Drug Dev Technol. 2010 Apr;8(2):219-27. doi: 10.1089/adt.2009.0232. Assay Drug Dev Technol. 2010. PMID: 20085460
• Use of the DiscoveRx Hit hunter cAMPII assay for direct measurement of cAMP in Gs and Gi GPCRs.
  Bradley J, McLoughlin D. Bradley J, et al. Methods Mol Biol. 2009;552:171-9. doi: 10.1007/978-1-60327-317-6_12. Methods Mol Biol. 2009. PMID: 19513649
• An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.
  Mistry R, Dowling MR, Challiss RA. Mistry R, et al. Br J Pharmacol. 2005 Feb;144(4):566-75. doi: 10.1038/sj.bjp.0706090. Br J Pharmacol. 2005. PMID: 15655507 Free PMC article.
• Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors.
  Schneider EH, Seifert R. Schneider EH, et al. Pharmacol Ther. 2010 Dec;128(3):387-418. doi: 10.1016/j.pharmthera.2010.07.005. Epub 2010 Aug 10. Pharmacol Ther. 2010. PMID: 20705094 Review.
• Regulation of cell proliferation by G proteins.
  Dhanasekaran N, Tsim ST, Dermott JM, Onesime D. Dhanasekaran N, et al. Oncogene. 1998 Sep 17;17(11 Reviews):1383-94. doi: 10.1038/sj.onc.1202242. Oncogene. 1998. PMID: 9779986 Review.

Cited by

• Impedance responses reveal β₂-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles.
  Stallaert W, Dorn JF, van der Westhuizen E, Audet M, Bouvier M. Stallaert W, et al. PLoS One. 2012;7(1):e29420. doi: 10.1371/journal.pone.0029420. Epub 2012 Jan 5. PLoS One. 2012. PMID: 22242170 Free PMC article.
• New Insights in Cannabinoid Receptor Structure and Signaling.
  Ye L, Cao Z, Wang W, Zhou N. Ye L, et al. Curr Mol Pharmacol. 2019;12(3):239-248. doi: 10.2174/1874467212666190215112036. Curr Mol Pharmacol. 2019. PMID: 30767756 Free PMC article. Review.
• Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells.
  Huang Y, Burns DJ, Rich BE, MacNeil IA, Dandapat A, Soltani SM, Myhre S, Sullivan BF, Lange CA, Furcht LT, Laing LG. Huang Y, et al. BMC Cancer. 2017 Mar 16;17(1):199. doi: 10.1186/s12885-017-3181-0. BMC Cancer. 2017. PMID: 28302091 Free PMC article.
• Gsα deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with Gsα mutations.
  Chen M, Berger A, Kablan A, Zhang J, Gavrilova O, Weinstein LS. Chen M, et al. Endocrinology. 2012 Sep;153(9):4256-65. doi: 10.1210/en.2012-1113. Epub 2012 Jun 25. Endocrinology. 2012. PMID: 22733970 Free PMC article.
• Novel tail and head group prostamide probes.
  Finnegan DF, Shelnut EL, Nikas SP, Chiang N, Serhan CN, Makriyannis A. Finnegan DF, et al. Bioorg Med Chem Lett. 2015 Mar 15;25(6):1228-31. doi: 10.1016/j.bmcl.2015.01.064. Epub 2015 Feb 4. Bioorg Med Chem Lett. 2015. PMID: 25701254 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon